BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 19107499)

  • 1. Inhibin A levels and severity of preeclampsia.
    Phupong V; Paiwattananupant K; Honsawek S
    Arch Gynecol Obstet; 2009 Aug; 280(2):183-6. PubMed ID: 19107499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum inhibin A level in preeclampsia and normotensive pregnancy.
    Paiwattananupant K; Phupong V
    Hypertens Pregnancy; 2008; 27(4):337-43. PubMed ID: 19003635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum and urine inhibin A but not free activin A are endocrine biomarkers of severe pre-eclampsia.
    Hamar BD; Buhimschi IA; Sfakianaki AK; Pettker CM; Magloire LK; Funai EF; Copel JA; Buhimschi CS
    Am J Obstet Gynecol; 2006 Dec; 195(6):1636-45. PubMed ID: 16959203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal serum activin, inhibin, human chorionic gonadotrophin and alpha-fetoprotein as second trimester predictors of pre-eclampsia.
    Davidson EJ; Riley SC; Roberts SA; Shearing CH; Groome NP; Martin CW
    BJOG; 2003 Jan; 110(1):46-52. PubMed ID: 12504935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibin-A levels and severity of hypertensive disorders due to pregnancy.
    Zeeman GG; Alexander JM; McIntire DD; Byrd W; Leveno KJ
    Obstet Gynecol; 2002 Jul; 100(1):140-4. PubMed ID: 12100816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uterine vein and maternal urinary levels of activin A and inhibin A in pre-eclampsia patients.
    Muttukrishna S; Hyett J; Paine M; Moodley J; Groome N; Rodeck C
    Clin Endocrinol (Oxf); 2006 Apr; 64(4):469-73. PubMed ID: 16584522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated maternal levels of the long pentraxin 3 (PTX3) in preeclampsia and intrauterine growth restriction.
    Cetin I; Cozzi V; Pasqualini F; Nebuloni M; Garlanda C; Vago L; Pardi G; Mantovani A
    Am J Obstet Gynecol; 2006 May; 194(5):1347-53. PubMed ID: 16647920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of fibrinogen and C-reactive protein with severity of preeclampsia.
    Ustün Y; Engin-Ustün Y; Kamaci M
    Eur J Obstet Gynecol Reprod Biol; 2005 Aug; 121(2):154-8. PubMed ID: 16054955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First trimester serum inhibin A in normal pregnant women.
    Phupong V; Hanprasertpong T; Honsawek S
    Arch Gynecol Obstet; 2008 Apr; 277(4):307-10. PubMed ID: 17957376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal serum inhibin-A and activin-A levels in the first trimester of pregnancies developing pre-eclampsia.
    Spencer K; Cowans NJ; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Oct; 32(5):622-6. PubMed ID: 18816493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid leptin levels in preeclampsia: relation to maternal serum leptin levels.
    Celik O; Hascalik S; Ozerol E; Hascalik M; Yologlu S
    Acta Obstet Gynecol Scand; 2004 Jun; 83(6):519-23. PubMed ID: 15144331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Plasma concentration of biochemical markers in pre-eclampsia-eclampsia and its association with the severity of the disease].
    Chavarría Olarte ME; González Gleason A; Lara González AL; Sojo Aranda I; García Paleta Y; Vital Reyes VS; Reyes Fuentes A
    Ginecol Obstet Mex; 2000 Sep; 68():385-93. PubMed ID: 11080945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of inhibin B, unlike inhibin A and activin A, are not altered in women with preeclampsia.
    Yair D; Eshed-Englender T; Kupferminc MJ; Geva E; Frenkel J; Sherman D
    Am J Reprod Immunol; 2001 Mar; 45(3):180-7. PubMed ID: 11270644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down syndrome biochemical markers and screening for preeclampsia at first and second trimester: correlation with the week of onset and the severity.
    Kang JH; Farina A; Park JH; Kim SH; Kim JY; Rizzo N; Elmakky A; Jun HS; Hahn WB; Cha DH
    Prenat Diagn; 2008 Aug; 28(8):704-9. PubMed ID: 18655226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal serum and amniotic fluid inhibin A levels in women who subsequently develop severe preeclampsia.
    Kim SY; Ryu HM; Yang JH; Kim MY; Ahn HK; Shin JS; Choi JS; Park SY; Kim JM; Lee BY; Kim DJ
    J Korean Med Sci; 2006 Jun; 21(3):452-6. PubMed ID: 16778388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal serum dyslipidemia occurs early in pregnancy in women with mild but not severe preeclampsia.
    Baker AM; Klein RL; Moss KL; Haeri S; Boggess K
    Am J Obstet Gynecol; 2009 Sep; 201(3):293.e1-4. PubMed ID: 19631926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes of serum cardiotrophin I and cystatin C in preeclampsia and clinical significance thereof].
    Yang XF; Lu DH; Wang ZP; He J; Wang HZ; Dong MY
    Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(45):3190-2. PubMed ID: 17313784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe preeclampsia is associated with high inhibin A levels and normal leptin levels at 7 to 13 weeks into pregnancy.
    Salomon LJ; Benattar C; Audibert F; Fernandez H; Duyme M; Taieb J; Frydman R
    Am J Obstet Gynecol; 2003 Dec; 189(6):1517-22. PubMed ID: 14710054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Early detection of possibilities for preeclampsia using VEGF1 and other serum analysis].
    Manolov V; Marinov B; Vasilev V
    Akush Ginekol (Sofiia); 2012; 51 Suppl 1():33-41. PubMed ID: 23236677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced third-trimester levels of soluble human leukocyte antigen G protein in severe preeclampsia.
    Hackmon R; Koifman A; Hyodo H; Glickman H; Sheiner E; Geraghty DE
    Am J Obstet Gynecol; 2007 Sep; 197(3):255.e1-5. PubMed ID: 17826409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.